Concepedia

Michael P. Adams

MP

8

Publications

246

Citations

8

H-Index

2004

Active since

Affiliations

Endo Pharmaceuticals (United States)(Current)

Prisma

Main Line Health

Michael P. Adams is an author at Endo Pharmaceuticals (United States) specializing in medicine, pharmacotherapy, and pharmacokinetics.

Top concepts

Publications per year

2004–2011

8

Publications

8

Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic Pathways

Michael P. Adams, Henry J. Pieniaszek, Arnold R. Gammaitoni et al. · The Journal of Clinical Pharmacology · 2005 · 70 citations

, , +17

Pharmacokinetics and Dose‐Proportionality of Oxymorphone Extended Release and Its Metabolites: Results of a Randomized Crossover Study

Michael P. Adams, Harry Ahdieh · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2004 · 65 citations · Full text

Single- and Multiple-Dose Pharmacokinetic and Dose-Proportionality Study of??Oxymorphone Immediate-Release Tablets

Michael P. Adams, Harry Ahdieh · Drugs in R&D · 2005 · 46 citations

, , +4

Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp

James Kulp, Sharon Levy, Melanie Fein et al. · Archives of Dermatological Research · 2010 · 17 citations

, , +7

Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants

Daniel J. Cushing, Michael P. Adams, Warren D. Cooper et al. · The Journal of Clinical Pharmacology · 2009 · 14 citations

, , +10

Rows per page

1–5 of 8